Creative Medical Valuation
| CELZ Stock | USD 2.08 0.02 0.95% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Creative Medical Tec shows a prevailing Real Value of $2.0 per share. The current price of the firm is $2.08. Our model approximates the value of Creative Medical Tec from analyzing the firm fundamentals such as return on equity of -0.98, and Current Valuation of 1.96 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Creative Medical's valuation include:
Price Book 1.3125 | Enterprise Value | Enterprise Value Ebitda (1.45) | Price Sales 1.2 K | Enterprise Value Revenue 327.2152 |
Overvalued
Today
Please note that Creative Medical's price fluctuation is dangerous at this time. Calculation of the real value of Creative Medical Tec is based on 3 months time horizon. Increasing Creative Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Creative Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Creative Stock. However, Creative Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.08 | Real 2.0 | Target 20.0 | Hype 2.08 | Naive 1.71 |
The intrinsic value of Creative Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Creative Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Creative Medical Technology helps investors to forecast how Creative stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Creative Medical more accurately as focusing exclusively on Creative Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Creative Medical's intrinsic value based on its ongoing forecasts of Creative Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Creative Medical's closest peers.
Creative Medical Cash |
|
Creative Medical Total Value Analysis
Creative Medical Technology is currently expected to have valuation of 1.96 M with market capitalization of 7.34 M, debt of 14.19 K, and cash on hands of 22.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Creative Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.96 M | 7.34 M | 14.19 K | 22.86 M |
Creative Medical Investor Information
The company has price-to-book (P/B) ratio of 1.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creative Medical Tec recorded a loss per share of 2.84. The entity last dividend was issued on the 3rd of February 2020. The firm had 1:10 split on the 12th of June 2023. Creative Medical Technology may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Creative Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Creative Medical has an asset utilization ratio of 0.16 percent. This suggests that the Company is making $0.001649 for each dollar of assets. An increasing asset utilization means that Creative Medical Technology is more efficient with each dollar of assets it utilizes for everyday operations.Creative Medical Profitability Analysis
Taking into consideration Creative Medical's profitability measurements, Creative Medical Technology may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in February. Profitability indicators assess Creative Medical's ability to earn profits and add value for shareholders.Net Loss | First Reported 2007-09-30 | Previous Quarter -1.2 M | Current Value -1.2 M | Quarterly Volatility 5.9 M |
For Creative Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Creative Medical Tec to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Creative Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Creative Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Creative Medical over time as well as its relative position and ranking within its peers.
Creative Medical Earnings per Share Projection vs Actual
By analyzing Creative Medical's earnings estimates, investors can diagnose different trends across Creative Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Creative Medical Technology is based on EPS before non-recurring items and includes expenses related to employee stock options.Creative Medical Ownership Allocation
Almost 93.1 percent of Creative Medical outstanding shares are held by general public with 1.0 (percent) owned by insiders and only 5.9 % by other corporate entities.Creative Medical Profitability Analysis
The company reported the previous year's revenue of 11 K. Net Loss for the year was (5.49 M) with profit before overhead, payroll, taxes, and interest of 3.6 K.About Creative Medical Valuation
Our relative valuation model uses a comparative analysis of Creative Medical. We calculate exposure to Creative Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Creative Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.6 K | 8 K | |
| Pretax Profit Margin | (574.32) | (545.60) | |
| Operating Profit Margin | (600.49) | (570.47) | |
| Net Loss | (574.32) | (545.60) | |
| Gross Profit Margin | 0.54 | 0.35 |
Creative Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.5 M | |
| Quarterly Earnings Growth Y O Y | 3.589 |
Creative Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Creative Medical Technology and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Creative we look at many different elements of the entity such as Creative's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Creative Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Creative Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Creative Medical's worth.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.